Accustem Sciences Inc.
corporate_fare Company Profile
Accustem Sciences Inc. (OTC:ACUT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 5 items for ACUT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 8/10. Across its 5 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for ACUT spans 10-Q, 10-K.
Recent high-impact activity:
- AccuStem Q3: $15,303 Cash Left, Going Concern Reaffirmed, $1.5M IPR&D Charge
- Accustem Sciences Q2 10-Q: Going Concern Warning, $12.9K Cash, Material Weakness
- Accustem Sciences Reports Zero Revenue, Q1 Net Loss Widens to $(485,883)
- Accustem Sciences Reports Q1 Loss, Critically Low Cash, and Immediate Liquidity Crisis
- Annual Report Reveals Going Concern Doubt, Critical Liquidity Issues, and Material Weakness in Controls
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 3,534 shares in ACUT as of the October 30, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.